Publicaciones en colaboración con investigadores/as de Hospital Universitario de Salamanca (8)

2022

  1. Case Report: Pharmacogenetics Applied to Precision Psychiatry Could Explain the Outcome of a Patient With a New CYP2D6 Genotype

    Frontiers in Psychiatry, Vol. 12

2021

  1. Economic impact of the application of a precision medicine model (5SPM) on psychotic patients

    Pharmacogenomics and Personalized Medicine, Vol. 14, pp. 1015-1025

  2. Review: Influence of the cyp450 genetic variation on the treatment of psychotic disorders

    Journal of Clinical Medicine, Vol. 10, Núm. 18

2020

  1. Application of a pharmacogenetics-based precision medicine model (5SPM) to psychotic patients that presented poor response to neuroleptic therapy

    Journal of Personalized Medicine, Vol. 10, Núm. 4, pp. 1-16

2018

  1. Usefulness of pharmacogenetic analysis in psychiatric clinical practice: A case report

    Clinical Psychopharmacology and Neuroscience, Vol. 16, Núm. 3, pp. 349-357

2017

  1. Eficacia, eficiencia y efectividad en el tratamiento multidimensional de la esquizofrenia: proyecto Rethinking

    Revista de Psiquiatria y Salud Mental, Vol. 10, Núm. 1, pp. 4-20

2010

  1. Frequency of sexual dysfunction in patients with a psychotic disorder receiving antipsychotics

    Journal of Sexual Medicine, Vol. 7, Núm. 10, pp. 3404-3413

1997

  1. SSRI-induced sexual dysfunction: Fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients

    Journal of Sex and Marital Therapy, Vol. 23, Núm. 3, pp. 176-194